Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.57 |
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | CES2 | O00748 | 1/20 | 0.57 |
| ▸ | CES1 | P23141 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | BCHE | P06276 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL548571 | 0.85 | L3MBTL1 (0.63) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL10405347 | 0.85 | CA1 (0.59) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL21815508 | 0.83 | L3MBTL1 (0.67) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL3920864 | 0.82 | CA1 (0.56) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL548572 | 0.82 | CA1 (0.65) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL11102906 | 0.82 | CA1 (0.56) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL3080854 | 0.82 | L3MBTL1 (0.61) | CA1CA2LMNAL3MBTL1HTT | |
| SCHEMBL10410659 | 0.81 | CA1 (0.63) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL959287 | 0.81 | CA1 (0.63) | CA1CA2CES2CES1ALDH1A1 | |
| SCHEMBL7294894 | 0.80 | CA1 (0.59) | CA1CA2CES2CES1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4299557-A1 | PHENYLACETIC ACID DERIVATIVE, USE THEREFOR, AND PRODUCTION INTERMEDIATE THEREOF | Sumitomo Chemical Company Limited (JP) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023249039-A1 | TRIAZINANE COMPOUND AND COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2023-12-28 | — | — | WO | disclosed |
| WO-2023243677-A1 | PLANT DISEASE CONTROL METHOD | 住友化学株式会社 | 2023-12-21 | — | — | WO | disclosed |
| WO-2023182391-A1 | METHOD FOR CONTROLLING PLANT DISEASES | 住友化学株式会社 | 2023-09-28 | — | — | WO | disclosed |
| EP-4223756-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-09 | — | — | EP | disclosed |
| EP-4223755-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-08-09 | — | — | EP | disclosed |
| WO-2023145769-A1 | γ-LACTAM COMPOUND AND COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2023-08-03 | — | — | WO | disclosed |
| WO-2023112988-A1 | METHOD FOR CONTROLLING NOXIOUS ARTHROPODS | 住友化学株式会社 | 2023-06-22 | — | — | WO | disclosed |
| US-20230150909-A1 | PHENYLACETIC ACID DERIVATIVE, USE THEREFOR, AND PRODUCTION INTERMEDIATE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-05-18 | — | — | US | disclosed |
| WO-2023277014-A1 | HETEROCYCLIC COMPOUND AND HARMFUL-ARTHROPOD-CONTROLLING COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2023-01-05 | — | — | WO | disclosed |
| WO-2023277015-A1 | HETEROCYCLIC COMPOUND AND RESISTANT HARMFUL ARTHROPOD-CONTROLLING METHOD FOR COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2023-01-05 | — | — | WO | disclosed |
| WO-2020158889-A1 | HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD CONTROL COMPOSITION CONTAINING SAME | 住友化学株式会社 | 2020-08-06 | — | — | WO | disclosed |
| US-20200109297-A1 | ENZYMATIC ANTIMICROBIAL AND ANTIFOULING COATINGS AND POLYMERIC MATERIALS | REACTIVE SURFACES, LTD., LLP (US) | 2020-04-09 | — | — | US | disclosed |
| EP-2324087-A2 | COATINGS AND SURFACE TREATMENTS HAVING ACTIVE ENZYMES AND PEPTIDES | McDaniel, Steven C. (US) | 2011-05-25 | — | — | EP | disclosed |
| WO-2009155115-A2 | COATINGS AND SURFACE TREATMENTS HAVING ACTIVE ENZYMES AND PEPTIDES | REACTIVE SURFACES, LTD. (US) | 2009-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150909-A1 | PHENYLACETIC ACID DERIVATIVE, USE THEREFOR, AND PRODUCTION INTERMEDIATE THEREOF | FAR1, NOTUM, ME1 | CA1 1184/4885CA2 454/4885CES2 2647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.